Chairman, President, and CEO Schwartz Norman D covered exercise/tax liability with 5,159 units of Bio-Rad A Common Stock and converted options into 10,477 units of Bio-Rad A Common Stock, increasing direct ownership by 1% to 438,238 units (SEC Form 4)